Granulation Aggregation

Similar documents
FROM SOLVENT TO AQUEOUS COATINGS. (Out of the Frying Pan...) Ralph E. Pondell. Coating Place, Inc. P.O. Box

Ph. D Synopsis. Mr. Mehul Pravinchandra Patel Page 1

(12) Patent Application Publication (10) Pub. No.: US 2003/ A1

Continuous Granulation Using a Twin-Screw Extruder. Lin Zhu, Ph.D. Manufacture Science and Technology AbbVie June, 2016

Comparison - Aqueous vs. Solvent based Ethylcellulose Films. H.S. Hall, K.D. Lillie & R.E. Pondell

ANNEXURE -2. Excipients profiles of Compritol ATO 888, Gelucire 43/01, HPMC and PVP and have been described in the following section.

EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (43) Date of publication: Bulletin 2010/39

LubriTose Mannitol Michael Crowley, Director of R&D, Excipients

EP B1 (19) (11) EP B1 (12) EUROPEAN PATENT SPECIFICATION

METOLOSE: CONTENTS PAGE

(51) Int Cl.: A61K 9/20 ( ) A61K 31/41 ( )

STARCH Application Data

Easy, fast and reliable!

Pharma & Food Solutions. POLYOX TM Water Soluble Resins Combining Flexibility with Consistency

Easy, fast and reliable!

Dr.N.Damodharan Professor and head Department of pharmaceutics SRM college of pharmacy

Coatings and Specialty Applications

Functional Excipients for Suppository Applications

(51) Int Cl.: A61K 9/20 ( ) A61K 31/5377 ( ) (56) References cited:

Emulsions. Purpose of emulsions and of emulsification:

Biopharmaceutics Dosage form factors influencing bioavailability Lec:5

REVISION OF MONOGRAPH ON TABLETS. Tablets

DRY SYRUPS SWAPNA.M. Ist semester DEPARTMENT OF PHARMACEUTICS UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES KAKATIYA UNIVERSITY, WARANGAL SEMINAR BY

SUSTAINED RELEASE TABLETS USING A PVA DC FORMULATION RESISTANT TO ALCOHOL INDUCED DOSE DUMPING

CHAPTER 5: FORMULATION OF SOLID DOSAGE FORM (TABLET & CAPSULES) INTRODUCTION

SK-influx A skin-identical lipid concentrate for enhanced skin moisturization and protection

13. SUPPOSITORY Suppository Bases. The active substance is prepared in a suitable bases. An ideal suppository bases should carry:

SENTRY TM POLYOX Water Soluble Resins

Content Uniformity of Direct Compression tablets

CAPMUL + CAPTEX + ACCONON = SEDDS

PHARMACEUTICAL AID PREPARED BY B.KIRUTHIGA LECTURER DEPT OF PHARMACEUTICAL CHEMISTRY

AAPS Annual Meeting, San Diego, CA November 12, 2017 Short Course. Pharmaceutical Excipients: Biopharmaceutical, QC and Regulatory Considerations

A Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac

Emulsions. BY Dr. Jarupa Viyoch. Dept. of Pharmaceutical Technology (2106)

Feed ingredients

TEGO Carbomer 341 ER Emulsion stabilizer, viscosity enhancer for aqueous solutions with high electrolyte tolerance

TABLET DESIGN AND FORMULATION

Ingredients adapted to a fit for use model. APIs allowed the fit for use strategy to work. There has been a shift to designed for purpose

Luwax LG Flakes. Technical Information. Montanic Ester Wax

International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:

Suppositories. Suppositories: 08/10/2016

Pharma Ingredients & Services. Ibuprofen. Technical Information. = Registered trademark of BASF group USP, Ph. Eur., JP

RESEARCH ARTICLE. Khemchand Gupta, S.B. Roy, Indrajeet Singhvi

TEGOSOFT APM Very high polar cosmetic oil with excellent thickening properties for surfactant formulas

Etat des travaux du GDP

The Function of Emollients in Skin Care

Kolliwax HCO. Technical Information. Hydrogenated castor oil powder for pharmaceutical use. = Registered trademark in many countries.

Baerlocher Additives for PVC. Lubricants

Edible Films, Coatings & Processing Aids

Excipient Quality & Trouble Shooting. By Seema Trivedi GM, Technical

Volker Bühler. Pharmaceutical Technology of BASF Excipients. Pharma Ingredients &Services. Welcome to more opportunities.

LIQUID PREPARATIONS FOR ORAL USE. Final text for addition to The International Pharmacopoeia (November 2007)

The binding performance of DFE Pharma Starch

Challenges and solutions for moisture sensitive API formulation

Baerlocher Additives for PVC. Lubricants. we add character to plastics

02/09/2016. Roles of Excipients in Pharmaceuticals:

B. semisolid materials consisting of hydrophilic and hydrophobic portions

TEGOSOFT DEC Emollient for formulations with a light skin feel

EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (43) Date of publication: Bulletin 2009/36

Emulsion stabilizer, viscosity enhancer for aqueous solutions with high electrolyte tolerance

(51) Int Cl.: A61K 9/20 ( ) A61K 31/4985 ( )

Alkyl Benzoate. Applications The multifunctional properties of Finsolv TPP allow it to be used for many applications in personal care areas:

Pharmaceutics I. Unit 7 EMULSIONS

Development of Up-to-Date Methods for USP/NF Excipient Standards

PALMSURF GMS Glyceryl Monostearate: The Versatile Food Emulsifier.

EXCIPIENTS. EXCELLENCE IN OLEOCHEMICAL EXCIPIENTS AND APIs PHARMA. IOI Oleo GmbH

Personal Care. Cremophor A Grades. Technical Information

PHARMACEUTICAL TECHNOLOGY REPORT. Introduction. Experimental Methods

CONTENTS PAGE. Please note: Preface Matrix system Selection of METOLOSE grades Specifications

International Journal of Innovative Pharmaceutical Sciences and Research

Attention is drawn to the following places, which may be of interest for search:

Large scale production

ABIL Care XL 80 Excellence in Stability, Flexibility and Sensory Properties

EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (43) Date of publication: Bulletin 2009/42

Re-compaction properties of lactose and microcrystalline cellulose

DESIGN AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FLURBIPROFEN

Formulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch

August 1, 2008 Supplemental Edition

Purposes of suppositories

STABILITY STUDIES OF FORMULATED CONTROLLED RELEASE ACECLOFENAC TABLETS

Folic Acid in Human Nutrition

Kolliphor P Grades. Technical Information. Poloxamers for Pharmaceutical Use. = Registered trademark of BASF Poloxamers Ph. Eur.

Pharmaceutical Studies on Formulation and Evaluation of Sustained Release Tablets Containing Certain Drugs

STARCH Proven and Trusted Excipient for Performance and Versatility EXCIPIENTS. Effective and economical disintegrant

TEPZZ _5 7B_T EP B1 (19) (11) EP B1 (12) EUROPEAN PATENT SPECIFICATION

(12) Patent Application Publication (10) Pub. No.: US 2008/ A1

Dissolution control of direct compression tablets in different test media using novel pregelatinized starch, Swelstar TM MX-1

A Legacy of Integrity and Service. Product Portfolio. Acme-Hardesty Sentry Parkway, Blue Bell, PA (800)

ABIL Care 85 Emulsifier for O/W emulsions with a velvety-silky skin feel

Application of Starches, Modified Starches and Starch Derivatives in Pharmaceutical Products

(51) Int Cl.: A61K 9/00 ( ) A61K 9/20 ( ) A61K 31/00 ( )

FORMULATION CHOICE. How and why they are chosen. Dr Andy Fowles On behalf of ECPA Specification Expert Group

FORMULATION AND DEVELOPMENT OF ER METOPROLAOL SUCCINATE TABLETS

Office europeen des brevets. Publication number: Applicant: Chugai Seiyaku Kabushiki Kaisha 5-1, 5-chome, Ukima Kita-ku Tokyo(JP)

ZHONGBAO CHEMICALS CO.,LTD

Mechanical Processing of Feeds. Anuraga Jayanegara

(12) Patent Application Publication (10) Pub. No.: US 2007/ A1

TEPZZ Z697_5A_T EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (51) Int Cl.: A61K 9/20 ( ) A61K 31/135 (2006.

ENHANCEMENT OF SOLUBILITY OF BICALUTAMIDE DRUG USING SOLID DISPERSION TECHNIQUE

LAB.2. Tablet Production Methods

Transcription:

Granulation Aggregation

Wet granulation Solvent granulation (crust granules) Binder granulation (sticked granules) Granulation liquid Water Water + alcohol mixture Macromolecular colloidal solution i.e.: starch, gelatine, polividon, cellulose ethers (MC, HEC, HPMC, etc.)

Wet granulation Drug(s) + excipient(s) Grinding Blending Agglomeration Granule/Pellet Aggregation Drying Press through sieves (particle size adjustment) Dispersion

Wet granulation

Melt granulation

Melt granulation

Melt granulation

Melt granulation Advantages Neither solvent nor water used in this process. Good alternative for water sensitive drugs. Fewer processing steps needed since wetting & drying phases eliminated, thus less time consuming There are no requirements on compressibility of active ingredients, entire procedure simple, continuous and efficient. Uniform dispersion of fine particle occurs. Good stability at varying ph and moisture levels. Safe application in humans due to their non-swellable and water insoluble nature. Clinically advantaged dosage forms, such as drug abuse and dose dumping deterrent technology. Sustained, modified and targeted release capabilities. Better content uniformity was obtained from HME process among granules of different size ranges. Reduced number of unit operations. Production of a wide range of performance dosage forms

Melt granulation Disadvantages Thermal process (drug/polymer stability). Requires high energy input. The melt technique is such that the process cannot be applied to heat-sensitive materials owing to the elevated temperatures involved. Lower-melting-point binder risks situations where melting or softening of the binder occurs during handling and storage of the agglomerates Higher-melting-point binders require high melting temperatures and can contribute to instability problems especially for heat-labile materials. Flow properties of the polymer are essential to processing. Limited number of available polymer

Melt granulation Hydrophylic binders Binder Typical melting range ( C) Gelucire 50/13 44-50 Poloxamer 188 50.9 PEG 2000 42-53 PEG 3000 48-63 PEG 6000 49-63 PEG 8000 54-63 PEG 10000 57-64 PEG 20000 53-66

Binder Melt granulation Hydrophobic binders Typical melting range ( C) Beeswax 56-60 Carnauba wax 75-83 Cetyl palmitate 47-50 Glycerin monostearate 47-63 Paraffin wax 47-65 Stearic acid 46-69 Glyceryl behenate 67-75 Glyceryl palmitostearate 48-57 Glyceryl stearate 54-63 Hydrogenated castor oil 62-86 Microcrystalline wax 58-72 Stearyl alcohol 56-60

Melt granulation Plasticizers Type Examples Citrate esters Fatty acid esters Sebacate esters Phatalate esters Glycol derivatives Others Triethyl citrate, tributyl citrate, acetyl triethyl citrate, acetyl tributyl citrate Butyl stearate, glycerol monostearate, stearyl alcohol Dibutyl sebacate Dietyl phtalate, dibutyl phtalate, dioctyl phosphate Polyethylene glycol, propylene glycol Triacetin, mineral oil, castor oil

Melt extrusion

Dry granulation

Dry granulation

Tasks & Preparations 1. Granule preparation o Pro-C-epT (high shear granulator) o Z-shaped kneader 2. Moisture content determination (analysis of drying process of granules) 3. Grinding, sieve analysis (ball grinder & vibrating sieve) 4. Mixing (rotating cube mixer)

Wet granulation Tasks & Preparations Granulatum piracetami (a., b., c.): Piracetam 42.0 g PVP 3.0 g Microcrystalline cellulose 50.0 g a. Aqua purificata 15.0 g b. Aqua purificata 20.0 g c. Aqua purificata 25.0 g Preparation parameters: Impeller (rpm): 1000 RPM Chopper (rpm): 1100 RPM Liquid addition: 10ml/min Pre-mixing: 3 min Pro-C-epT High shear granulator

Wet granulation Tasks & Preparations Pellet preparation (a., b.): Avicel PH 102 65.00 g Ethylcellulose 4.00 g Lactose 48.00 g Preparation parameters: Pre-mixing: 3 min Impeller (rpm): 1000 RPM Chopper (rpm): 1100 RPM Liquid addition: 10ml/min Pro-C-epT High shear granulator Total liquid (Aqua purificata): a. 52 ml b. 70 ml

Wet granulation Tasks & Preparations Granule preparation I. Solani amylum 238.0 g Lactose 710.0 g II. Aqua purificata Solani amylum 170.0 g 30.0 g Z-shaped kneader Make a suspension with a cold water from the starch. Heat the liquid with water-bath while the starch becomes gelatinous (10-15 min). Cool down the granulating liquid to 40 C and refill the evaporated water. Homogenise the sieved powders, and knead it with small details of granulating liquid in Z-shaped kneader. Break the wet stuff through the granulating sieve IV (1.2 mm). Use oscillating granulator.